alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
UNPUBLISHED

UNITED STATES COURT OF APPEALS

FOR THE FOURTH CIRCUIT

No. 16-6218

UNITED STATES OF AMERICA,

Plaintiff – Appellee,

v.

LAKEESHI SIMS,

Defendant - Appellant.

Appeal from the United States District Court for the District of 

South Carolina, at Anderson. J. Michelle Childs, District 

Judge. (8:12-cr-00787-JMC-1; 8:15-cv-02834-JMC)

Submitted: August 5, 2016 Decided: August 19, 2016

Before WYNN and DIAZ, Circuit Judges, and HAMILTON, Senior 

Circuit Judge.

Dismissed by unpublished per curiam opinion.

Lakeeshi Sims, Appellant Pro Se. Carrie Fisher Sherard, 

Assistant United States Attorney, Greenville, South Carolina, 

for Appellee.

Unpublished opinions are not binding precedent in this circuit.
2

PER CURIAM:

Lakeeshi Sims seeks to appeal the district court’s order 

denying relief on her 28 U.S.C. § 2255 (2012) motion. The order 

is not appealable unless a circuit justice or judge issues a 

certificate of appealability. 28 U.S.C. § 2253(c)(1)(B) (2012). 

A certificate of appealability will not issue absent “a 

substantial showing of the denial of a constitutional right.” 

Id. § 2253(c)(2). When the district court denies relief on the 

merits, a prisoner satisfies this standard by demonstrating that 

“reasonable jurists would find that the district court’s 

assessment of the constitutional claims [is] debatable or 

wrong.” Slack v. McDaniel, 529 U.S. 473, 484 (2000); see

Miller-El v. Cockrell, 537 U.S. 322, 336-38 (2003). When the 

district court denies relief on procedural grounds, the prisoner 

must demonstrate both that the dispositive procedural ruling is 

debatable, and that the motion states a debatable claim of the 

denial of a constitutional right. Slack, 529 U.S. at 484-85. 

We have independently reviewed the record and conclude that 

Sims has not made the requisite showing. Accordingly, we deny a 

certificate of appealability and dismiss the appeal. The motion 

for preparation of a transcript at government expense is denied. 

We dispense with oral argument because the facts and legal
3

contentions are adequately presented in the materials before 

this court and argument would not aid the decisional process.

DISMISSED
§ 58.113 Mixtures of articles with carriers. ( a ) For each test or control article that is mixed with a carrier, tests by appropriate analytical methods shall be conducted: ( 1 ) To determine the uniformity of the mixture and to determine, periodically, the concentration of the test or control article in the mixture.
( 2 ) To determine the stability of the test and control articles in the mixture as required by the conditions of the study either: ( i ) Before study initiation, or
( ii ) Concomitantly according to written standard operating procedures which provide for periodic analysis of the test and control articles in the mixture.
( b ) [Reserved]
( c ) Where any of the components of the test or control article carrier mixture has an expiration date, that date shall be clearly shown on the container. If more than one component has an expiration date, the earliest date shall be shown.
[43 FR 60013, Dec. 22, 1978, as amended at 45 FR 24865, Apr. 11, 1980; 52 FR 33781, Sept. 4, 1987]
<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
FINANCIAL STATEMENTS OF HANCOCK FABRICS, INC. FOR THE SIX MONTHS ENDED
AUGUST 3, 1997 AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH 
FINANCIAL STATEMENTS.
</LEGEND>
<MULTIPLIER> 1,000
       
<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          FEB-01-1998
<PERIOD-START>                             FEB-03-1997
<PERIOD-END>                               AUG-03-1997
<CASH>                                           5,731
<SECURITIES>                                         0
<RECEIVABLES>                                    1,547
<ALLOWANCES>                                         0
<INVENTORY>                                    143,542
<CURRENT-ASSETS>                               157,100
<PP&E>                                          16,800
<DEPRECIATION>                                       0
<TOTAL-ASSETS>                                 182,954
<CURRENT-LIABILITIES>                           49,245
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                           279
<OTHER-SE>                                     105,922
<TOTAL-LIABILITY-AND-EQUITY>                   106,201
<SALES>                                        171,954
<TOTAL-REVENUES>                               171,954
<CGS>                                           88,431
<TOTAL-COSTS>                                        0
<OTHER-EXPENSES>                                76,886
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                  95
<INCOME-PRETAX>                                  6,542
<INCOME-TAX>                                     2,514
<INCOME-CONTINUING>                              4,028
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                     4,028
<EPS-PRIMARY>                                      .19
<EPS-DILUTED>                                      .19
        

</TABLE>
§ 146.126 Frozen concentrate for colored lemonade. ( a ) Frozen concentrate for colored lemonade conforms to the definition and standard of identity prescribed for frozen concentrate for lemonade by § 146.120, except that it is colored with a safe and suitable fruit juice, vegetable juice, or any such juice in concentrated form, or with any other color additive ingredient suitable for use in food, including artificial coloring, used in conformity with regulations established pursuant to section 721 of the Federal Food, Drug, and Cosmetic Act.
( b ) The name of the food is “Frozen concentrate for ______ lemonade”, the blank being filled in with the word describing the color: for example, “Frozen concentrate for pink lemonade”.
( c ) *Label declaration.* Each of the ingredients used in the food shall be declared on the label as required by the applicable sections of parts 101 and 130 of this chapter.
[42 FR 14433, Mar. 15, 1977, as amended at 58 FR 2881, Jan. 6, 1993]
§ 21.21 Changes in systems and new systems. ( a ) The Food and Drug Administration shall notify the designated Department official, the Office of Management and Budget (Information Systems Division), and the Congress of proposals to change or establish Privacy Act Record Systems in accordance with procedures of the Department and the Office of Management and Budget.
( b ) The Food and Drug Administration shall issue a notice, in accordance with paragraph (d) of this section and § 21.20(b), of any change in a Privacy Act Record System which: ( 1 ) Increases the number or types of individuals about whom records are maintained;
( 2 ) Expands the type or amount of information about individuals that is maintained;
( 3 ) Increases the number of categories of agencies or other persons who may have access to those records;
( 4 ) Alters the manner in which the records are organized so as to change the nature or scope of those records, such as the combining of two or more existing systems;
( 5 ) Modifies the way in which the system operates or its location(s) in a manner that alters the process by which individuals can exercise their rights under this part, such as the ways in which they seek access or request amendment of a record; or
( 6 ) Changes the equipment configuration on which the system is operated so as to create the potential for greater access, such as adding a telecommunications capability.
( c ) The Food and Drug Administration shall issue a notice of its intention to establish new Privacy Act Record Systems in accordance with paragraph (d) of this section and § 21.20(b).
( d ) Notices under paragraphs (b) and (c) of this section shall be published in the Federal Register for comment at least 30 days prior to implementation of the proposed changes or establishment of new systems. Interested persons shall have the opportunity to submit written data, views, or arguments on such proposed new uses or systems.
§ 74.3602 D&C Violet No. 2. ( a ) *Identity and specifications.* The color additive D&C Violet No. 2 shall conform in identity and specifications to the requirements of § 74.1602(a)(1) and (b).
( b ) *Uses and restrictions.* ( 1 ) The color additive, D&C Violet No. 2, may be safely used for coloring contact lenses in amounts not to exceed the minimum reasonably required to accomplish the intended coloring effect.
( 2 ) D&C Violet No. 2 may be safely used for coloring sutures for use in surgery subject to the following conditions: ( i ) At a level not to exceed 0.2 percent by weight of the suture material for coloring copolymers of 90 percent glycolide and 10 percent L-lactide synthetic absorbable sutures for use in general and ophthalmic surgery; and
( ii ) At a level not to exceed 0.3 percent by weight of the suture material for coloring polydioxanone synthetic absorbable sutures for use in general and ophthalmic surgery.
( iii ) At a level not to exceed 0.25 percent by weight of the suture material for coloring poliglecaprone 25 (ε-caprolactone/glycolide copolymer) synthetic absorbable sutures for use in general surgery.
( iv ) At a level not to exceed 0.1 percent by weight of the suture material for coloring poly(ε-caprolactone) absorbable sutures for use in general surgery.
( v ) At a level not to exceed 0.2 percent by weight of the suture material for coloring glycolide/dioxanone/trimethylene carbonate tripolymer absorbable sutures for use in general surgery.
( vi ) At a level not to exceed 0.2 percent by weight of the suture material for coloring absorbable sutures prepared from homopolymers of glycolide for use in general surgery.
( 3 ) The color additive, D&C Violet No. 2, may be safely used for coloring polymethylmethacrylate intraocular lens haptics at a level not to exceed 0.2 percent by weight of the haptic material.
( 4 ) The color additive, D&C Violet No. 2, may be safely used for coloring absorbable meniscal tacks made from poly (L-lactic acid) at a level not to exceed 0.15 percent by weight of the tack material.
( 5 ) Authorization for these uses shall not be construed as waiving any of the requirements of sections 510(k), 515, and 520(g) of the Federal Food, Drug, and Cosmetic Act with respect to the medical devices in which the color additive is used.
( c ) *Labeling.* The label of the color additive shall conform to the requirements of § 70.25 of this chapter.
( d ) *Certification.* All batches of D&C Violet No. 2 shall be certified in accordance with regulations in part 80 of this chapter.
[52 FR 19722, May 27, 1987, as amended at 55 FR 18868, May 7, 1990; 58 FR 60109, Nov. 15, 1993; 59 FR 11720, Mar. 14, 1994; 63 FR 20098, Apr. 23, 1998; 64 FR 32805, June 18, 1999; 65 FR 46344, July 28, 2000]
§ 349.60 Labeling of ophthalmic demulcent drug products. ( a ) *Statement of identity.* The labeling of the product contains the established name of the drug(s), if any, and identifies the product as a “lubricant” or “demulcent (lubricant)” (select one of the following: “eye” or “ophthalmic”) “(insert dosage form, e.g., drops).”
( b ) *Indications.* The labeling of the product states, under the heading “Indications,” one or more of the following phrases: ( 1 ) “For the temporary relief of burning and irritation due to dryness of the eye.”
( 2 ) “For the temporary relief of discomfort due to minor irritations of the eye or to exposure to wind or sun.”
( 3 ) “For use as a protectant against further irritation or to relieve dryness of the eye.”
( 4 ) “For use as a lubricant to prevent further irritation or to relieve dryness of the eye.”
( c ) *Warnings.* In addition to the warnings in § 349.50, the labeling of the product contains the following warnings under the heading “Warnings” for products containing any ingredient identified in § 349.12: ( 1 ) “If you experience eye pain, changes in vision, continued redness or irritation of the eye, or if the condition worsens or persists for more than 72 hours, discontinue use and consult a doctor.”
( 2 ) “If solution changes color or becomes cloudy, do not use.”
( d ) *Directions.* The labeling of the product contains the following information under the heading “Directions”: Instill 1 or 2 drops in the affected eye(s) as needed.
§ 573.615 Marine microalgae. The food additive, marine microalgae, may be safely used as a source of docosahexaenoic acid (DHA) and other omega-3 fatty acids in accordance with the following prescribed conditions: ( a ) The additive is dried whole cells of nonviable, nontoxigenic, nonpathogenic *Schizochytrium* sp. algae grown as a pure culture.
( b ) The additive is used in complete, dry adult maintenance food for dogs in accordance with good manufacturing and feeding practices not to exceed 16.5 pounds per ton (7.5 kilograms (kg) per 1000 kg) of complete, dry, adult maintenance dog food.
( c ) The additive consists of not less than 17.0 percent (4*Z,*7*Z,*10*Z,*13*Z,*16*Z,*19*Z*)-docosa-4,7,10,13,16,19-hexaenoic acid (docosahexaenoic acid or DHA).
( d ) The additive meets the following specifications: ( 1 ) Not less than 40 percent crude fat;
( 2 ) Not more than 12 percent ash;
( 3 ) Not more than 8 percent unsaponifiable matter;
( 4 ) Not more than 5 percent insoluble impurities;
( 5 ) Not more than 5 percent free fatty acids; and
( 6 ) Not more than 6 percent water.
( e ) To ensure the safe use of the additive, in addition to other information required by the Federal Food, Drug, and Cosmetic Act: ( 1 ) The label and labeling of the additive, any feed premix, and complete feed, shall contain the name of the additive, marine microalgae.
( 2 ) The label and labeling of the additive and any feed premix shall also contain: ( i ) A statement to indicate that the maximum use level of the additive shall not exceed 16.5 pounds per ton (7.5 kg per 1000 kg) of complete, dry, adult maintenance dog food.
( ii ) Adequate directions for use.
[83 FR 19935, May 7, 2018]
effect to this First Amendment and (ii) all of the representations and warranties contained inthe Credit Agreement or the other Credit Documents are true and correct in all material respects onthe First Amendment Effective Date both immediately before and after giving effect to this FirstAmendment, with the same effect as though such representations and warranties had been made on andas of the First Amendment Effective Date (it being understood that any representation or warrantymade as of a specific date shall be true and correct in all material respects as of such specificdate).     2.     This First Amendment is limited as specified and shall not constitute a modification,acceptance or waiver of any other provision of the Credit Agreement or any other Credit Document.     3.     This First Amendment may be executed in any number of counterparts and by the differentparties hereto on separate counterparts, each of which counterparts when executed and deliveredshall be an original, but all of which shall together constitute one and the same instrument. Acomplete set of counterparts shall be lodged with the U.S. Borrower and the Administrative Agent.     4.     **THIS FIRST AMENDMENT AND THE RIGHTS AND OBLIGATIONS OF THE PARTIES HEREUNDER SHALL BECONSTRUED IN ACCORDANCE WITH AND GOVERNED BY THE LAW OF THE STATE OF NEW YORK.**     5.     This First Amendment shall become effective on the date (the “First Amendment EffectiveDate”) when each of the Borrowers and Lenders constituting the ABL Required Lenders shall havesigned a counterpart hereof (whether the same or different counterparts) and shall have delivered(including by way of facsimile or other electronic transmission) the same to White & Case LLP, 1155Avenue of the Americas, New York, NY 10036 Attention: May Yip (facsimile number: 212-354-8113 /e-mail address: myip@whitecase.com).     6.     From and after the First Amendment Effective Date, all references in the Credit Agreementand each of the other Credit Documents to the Credit Agreement shall be deemed to be references tothe Credit Agreement, as modified hereby.*     *     *
-2-

 
     IN WITNESS WHEREOF, the parties hereto have caused their duly authorized officers to executeand deliver this Amendment as of the date first above written.      EXIDE TECHNOLOGIES, as the U.S. Borrower
§ 524.1484d Neomycin, hydrocortisone, and tetracaine otic ointment. ( a ) *Specifications.* The product contains 5 milligrams of neomycin sulfate, equivalent to 3.5 milligrams of neomycin base, 5 milligrams of hydrocortisone acetate, and 5 milligrams of tetracaine hydrochloride in each gram of ointment.
( b ) *Sponsor.* See No. 054771 in § 510.600(c) of this chapter.
( c ) *Conditions of use in dogs and cats* — ( 1 ) *Amount.* Instill a quantity of ointment sufficient to fill the external ear canal; may be applied one to three times daily.
( 2 ) *Indications for use.* For the treatment of ear canker and other inflammatory conditions of the external ear canal, acute otitis externa and, to a lesser degree, chronic otitis externa.
( 3 ) *Limitations.* Federal law restricts this drug to use by or on the order of a licensed veterinarian.
[40 FR 13873, Mar. 27, 1975, as amended at 49 FR 21922, May 24, 1984; 79 FR 10970, Feb. 27, 2014]
```

[Congressional Bills 118th Congress]
[From the U.S. Government Publishing Office]
[H.R. 7464 Introduced in House (IH)]

<DOC>

118th CONGRESS
  2d Session
                                H. R. 7464

To amend title 38, United States Code, to provide for access standards 
with respect to the provision by the Department of Veterans Affairs of 
  hospital care, medical services, or extended care services that are 
         applicable to certain veterans with mental disorders.

_______________________________________________________________________

                    IN THE HOUSE OF REPRESENTATIVES

                           February 28, 2024

  Mr. Yakym introduced the following bill; which was referred to the 
                     Committee on Veterans' Affairs

_______________________________________________________________________

                                 A BILL

 
To amend title 38, United States Code, to provide for access standards 
with respect to the provision by the Department of Veterans Affairs of 
  hospital care, medical services, or extended care services that are 
         applicable to certain veterans with mental disorders.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Sergeant Ted Grubbs Mental 
Healthcare for Disabled Veterans Act''.

SEC. 2. DEPARTMENT OF VETERANS AFFAIRS COMMUNITY CARE ACCESS STANDARDS 
              FOR CERTAIN VETERANS WITH MENTAL DISORDERS.

    Section 1703B(a) of title 38, United States Code, is amended by 
adding at the end the following new paragraph:
    ``(3) The access standards required under this subsection shall 
provide that in the case of a covered veteran with a service-connected 
mental disorder rated at 50 percent or more, the Department shall 
furnish hospital care, medical services, or extended care services for 
such mental disorder within five days of the date on which the covered 
veteran requests such care or services.''.
                                 <all>
```
IIB 

118TH CONGRESS 

2D SESSION H. R. 7607 

IN THE SENATE OF THE UNITED STATES 

JUNE 4, 2024 

Received; read twice and referred to the Committee on Homeland Security and 

Governmental Affairs 

AN ACT 

To designate the facility of the United States Postal Service 

located at Block 1025, Lots 18 & 19, Northeast Corner 

of US Route 9 South and Main Street in the Township 

of Middle, County of Cape May, New Jersey, as the 

‘‘George Henry White Post Office Building’’. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 


ssavage on LAPJG3WLY3PROD with BILLS
2 

HR 7607 RFS

1 SECTION 1. GEORGE HENRY WHITE POST OFFICE BUILD2 ING. 

3 (a) DESIGNATION.—The facility of the United States 

4 Postal Service located at Block 1025, Lots 18 & 19, 

5 Northeast Corner of US Route 9 South and Main Street 

6 in the Township of Middle, County of Cape May, New Jer7 sey, shall be known and designated as the ‘‘George Henry 

8 White Post Office Building’’. 

9 (b) REFERENCES.—Any reference in a law, map, reg10 ulation, document, paper, or other record of the United 

11 States to the facility referred to in subsection (a) shall 

12 be deemed to be a reference to the ‘‘George Henry White 

13 Post Office Building’’. 

Passed the House of Representatives June 3, 2024. 

Attest: KEVIN F. MCCUMBER, 

Clerk. 


ssavage on LAPJG3WLY3PROD with BILLS
---

EXHIBIT 13.A



CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002



In connection with Amendment No. 2 to the
Annual Report of Petaquilla Minerals Ltd. (the Company) on Form 20-F for the fiscal period ended May 31, 2009, as filed with the Securities and Exchange Commission on the date hereof (the Report), I, Joao Manuel , President and Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of my knowledge:



| |    |  |                                                                                                                                                      
| | -- |  | -----------------------------------------------------------------------------------------------------------------------------------------------------
| | 1. |  | The Report fully complies with the requirements of Section 13(a) or 15(d), as applicable, of the Securities Exchange Act of 1934, as amended; and    
| |    |  |                                                                                                                                                      
| | 2. |  | The information contained in the Report fairly presents, in all materials respects, the financial condition and results of operations of the Company.





|                               | 
|------------------------------ | 
|/s/ Joao Manuel                | 
|Joao Manuel                    | 
|(principal executive officer ) | 



Dated:  January 29, 2010





The foregoing certification is being furnished solely to accompany the Report pursuant to 18 U.S.C § 1350, and is not being filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and is not to be incorporated by reference into any filing of the Company, whether made before or after the date hereof, regardless of any general incorporation language in such filing.





---
#### § 601.94 Promotional materials.

For biological products being considered for approval under this subpart, unless otherwise informed by the agency, applicants must submit to the agency for consideration during the preapproval review period copies of all promotional materials, including promotional labeling as well as advertisements, intended for dissemination or publication within 120 days following marketing approval. After 120 days following marketing approval, unless otherwise informed by the agency, the applicant must submit promotional materials at least 30 days prior to the intended time of initial dissemination of the labeling or initial publication of the advertisement.